Introduction to Techcyte

Techcyte is a leading company specializing in developing an AI platform for anatomic and clinical pathology, delivering the world’s first unified solution that integrates these two fields into a seamless system.
Advanced AI Platform in Pathology Diagnosis
With the mission to revolutionize healthcare workflows, Techcyte leverages artificial intelligence technology to assist pathologists, enhance diagnostic efficiency, and improve the quality of life for healthcare professionals.
Since 2013, the company has led the field of digital diagnostics, creating powerful machine learning solutions for cellular and liquid-based environments, helping laboratories and healthcare professionals advance in digital diagnosis.

History and Development of Techcyte

Techcyte was founded in 2013 with the goal of leading digital diagnostics into the future.
From its early days, the company has focused on developing AI tools to support the healthcare field, particularly pathology.

Over more than a decade, Techcyte has continuously innovated, evolving from a tech startup into a comprehensive solution provider for laboratories worldwide.
The company’s growth is closely tied to advancements in AI technology, where machine learning is applied to analyze medical images with high accuracy and speed.
Today, Techcyte has become a symbol of the integration between technology and healthcare, helping professionals overcome traditional challenges in pathology diagnosis.
With continuous investment in research and development, the company has expanded its scope of operations, delivering tailored solutions for various medical applications, from clinical diagnosis to scientific research.

Mission and Vision of Techcyte in the Healthcare Field

Techcyte’s core mission is to transform the healthcare industry through AI-assisted solutions, harnessing the power of artificial intelligence tools to drive progress in the field.
The company is committed to providing comprehensive solutions that deliver an intuitive and efficient experience from sample preparation to workflow implementation and image analysis.
Techcyte’s vision emphasizes unifying pathology, creating seamless AI, intelligent workflows, and superior speed without compromising quality.
Built by pathologists for pathologists, Techcyte’s platform not only focuses on technology but also prioritizes the real-world needs of users, ensuring that every solution contributes to improving efficiency and accuracy in diagnosis.
In the context of growing digital healthcare, Techcyte aims to make AI diagnosis more accessible, helping laboratories worldwide achieve better results at reasonable costs.

Key Products and Solutions of Techcyte

Techcyte offers a range of AI-based products and solutions focused on digital pathology, AI diagnosis, clinical pathology, and research applications.
The core platform is Fusion AP, a unified digital pathology system that integrates anatomic and clinical pathology, recently certified CE-IVDR.
This product enables laboratories to manage workflows seamlessly, from image analysis to result reporting.
In addition, the Fusion Frozen Section Suite supports frozen section procedures, allowing pathologists to quickly process tissue samples during surgery.
One of the breakthrough products is the Techcyte SureView Cervical Cytology System, an AI-based digital cervical cytology diagnostic system that enables early detection of cellular abnormalities with high accuracy.

The Fusion Parasitology Suite uses deep convolutional neural networks to detect protozoan and helminth parasites in stool samples, delivering superior performance in parasite diagnosis.
Similarly, the Fusion Bacteriology Suite is for bacteriology, Fusion Hematology Suite for hematology, and Fusion Organ Donation Suite supports organ donation processes.
These solutions cover clinical and anatomic pathology, with AI tools for image analysis, data management, and customized workflows. They target human medical laboratories, focusing on areas such as cervical cytology, parasitology, bacteriology, hematology, and organ donation.

Key Features of the Techcyte Fusion Platform

Techcyte’s Fusion platform stands out with many advanced features that optimize the diagnostic process.
The system includes image optimization and acquisition, custom workflows with AI tools, high security and scalability. It integrates IMS, viewer, and storage for slide management, along with data management and AI algorithms. Reporting and LIS integration ensure smooth connectivity with laboratory information systems. The platform complies with strict standards such as FDA, CE, HIPAA, ISO, GDPR, and SOC2, providing maximum data security.

With seamless AI, intelligent workflows, and fast speed, Fusion allows pathologists to focus on their expertise instead of repetitive tasks, thereby improving overall efficiency in digital pathology diagnosis.

Achievements and Contributions of Techcyte in the Healthcare Industry

Techcyte has achieved many significant milestones, solidifying its leadership in AI diagnosis. In March 2025, the company announced Fusion as the first unified digital pathology platform integrating anatomic and clinical pathology, marking a turning point in the industry.
Fusion AP has received CE-IVDR certification, expanding its applications in Europe. In October 2025, Techcyte published research on detecting protozoan and helminth parasites using deep convolutional neural networks, contributing to scientific progress.
The company also emphasizes research and development, with blog articles sharing insights on AI applications in pathology, helping the medical community stay updated with the latest knowledge.

The Future of Techcyte

Techcyte not only focuses on products but also encourages career development for talented individuals passionate about medical technology. The company invites demos to experience AI-based digital diagnostic tools, helping laboratories evaluate real-world benefits.
In the future, Techcyte continues to lead trends in digital pathology, with a focus on intelligent AI and efficient workflows. If you are a healthcare professional or seeking AI diagnostic solutions, Techcyte is the ideal choice to elevate your laboratory.

Strategic Partners and Collaborations of Techcyte

Techcyte has built strong partnerships to expand globally.
In February 2024, the company entered a strategic collaboration with BD to provide an AI-based digital cervical cytology diagnostic system, combining technologies from both sides to improve diagnosis quality.
In January 2024, Techcyte collaborated with Mayo Clinic Platform to transform global pathology practice, leveraging large-scale data platforms to develop advanced AI solutions. These collaborations not only bring technological value but also expand the market, allowing Techcyte to reach more laboratories and healthcare professionals.
In early 2026, Lintech JSC provides Techcyte’s products and services in the Vietnamese market. This is an opportunity for Lintech JSC to bring world-leading digital pathology AI platforms from Techcyte directly to Vietnamese laboratories, hospitals, and medical centers, including:

• Fusion AP platform (unified anatomic and clinical digital pathology system, CE-IVDR certified)
• Techcyte SureView Cervical Cytology System (AI-based cervical cytology diagnosis)
• Fusion Parasitology Suite, Fusion Bacteriology Suite, Fusion Hematology Suite, and other solutions

Lintech JSC offers comprehensive support from consultation, product demos, user training, system integration to warranty and maintenance services, with the goal of helping healthcare facilities easily adopt AI technology into daily pathology diagnostic processes, improving accuracy, speed, and overall efficiency.